Advertisement
NuAire
NuAire

The Scientist

» FDA and cell & molecular biology

Most Recent

image: Baldness Genes Discovered?

Baldness Genes Discovered?

By | March 26, 2012

Researchers say they've found key molecular clues to a problem that plagues 80 percent of men.

0 Comments

image: Debate over RNA Transcription

Debate over RNA Transcription

By | March 19, 2012

Researchers question earlier findings of a new mechanism for gene regulation.

2 Comments

image: A FASTer FDA?

A FASTer FDA?

By | March 19, 2012

A new bill recently debated in the US Congress seeks to streamline the approval process for drugs.

0 Comments

image: Slipping from the Top?

Slipping from the Top?

By | March 14, 2012

Experts and the American public worry that the country is at risk of losing its global leadership position in scientific research.

24 Comments

image: Self-prescribing Patients?

Self-prescribing Patients?

By | March 13, 2012

The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.

4 Comments

image: Designer Aspirin Fights Cancer

Designer Aspirin Fights Cancer

By | March 5, 2012

Early experiments show that a hybrid form of the common pain reliever can effectively inhibit the growth of many tumor types.

0 Comments

image: Are the Kids Alright?

Are the Kids Alright?

By | March 1, 2012

Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?

6 Comments

image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44

0 Comments

image: Delivering Silence

Delivering Silence

By | March 1, 2012

Using RNA viruses to silence genes could optimize tissue targeting while reducing toxicity.

0 Comments

image: How the Pediatric Laws Work

How the Pediatric Laws Work

By | March 1, 2012

The Pediatric Research Equity Act (PREA) of 2003 requires that companies developing new drugs that could be used to treat a condition in children perform clinical trials in kids before winning FDA approval. 

0 Comments

Advertisement

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. A Case of Sexual Ambiguity, 1865
    Foundations A Case of Sexual Ambiguity, 1865

    This year marks the 150th anniversary of an autopsy report describing the first known case of a sexual development disorder.

  3. Influential Cancer Biologist Dies
  4. Image of the Day: Colorful Corn
Advertisement
Advertisement
Life Technologies